• Global kratom capsules market size was valued at USD 218 million in 2024. The market is projected to grow from USD 236 million in 2025 to USD 376 million by 2032, exhibiting a CAGR of 8.2% during the forecast period.
Email:
Report Studies
• Kratom capsules contain Mitragyna speciosa, a tropical evergreen tree native to Southeast Asia. These capsules are primarily used for pain relief, mood enhancement, and opioid withdrawal management. The active alkaloids, mitragynine and 7-hydroxymitragynine, interact with opioid receptors while showing lower abuse potential than traditional opioids. Products are categorized by vein color (red, green, white) with varying potency levels.
Email: help@intelmarketresearch.com +91 9169164321
By Types
•Red Vein Kratom Capsules
•Subtypes: Maeng Da, Bali, Borneo, and others
•Green Vein Kratom Capsules
•White Vein Kratom Capsules
•Subtypes: White Thai, White Maeng Da, and others
•Specialty Blends
By Applications
• Pain management • Energy and focus enhancement • Relaxation and stress relief • Opioid withdrawal management • Others
Key Players :
•VivaZen (U.S.)
•MIT45 (U.S.)
•Kats Botanicals (U.S.)
•Club13 Herbals (U.S.)
•DBZ Enterprises - K-Chill, Kryptic (U.S.)
•Kraken Kratom (U.S.)
•Super Speciosa (U.S.)
Email: help@intelmarketresearch.com +91 9169164321
